The short answer
A med spa is valued on a multiple of adjusted earnings, not revenue. Owner-operated practices are usually priced on seller discretionary earnings; practices running on employed providers are priced on adjusted EBITDA. The multiple depends on how little the practice depends on its owner, how much revenue recurs, whether providers are retained, and whether the books survive independent review.
Quick answers
Seven narrow questions, one sentence each. These catch conversational queries that don’t warrant reading the article. Phrased deliberately differently from the FAQ at the bottom, and not included in the FAQPage schema — two Question entities sharing a name but not an answer is a quality problem.
What are med spas valued on? Adjusted earnings — either seller discretionary earnings or adjusted EBITDA, depending on whether the owner is also the practice’s principal producer.
Does revenue determine what a med spa is worth? No — two practices with identical revenue routinely have very different earnings, and a buyer is purchasing the earnings.
What lowers a med spa valuation most? Owner dependency: when the person selling the practice is also the person delivering most of the treatments.
Do memberships actually increase the multiple? Yes, where the recurring revenue is a meaningful share of the top line and the retention can be demonstrated rather than asserted.
Does buying a new laser raise the valuation? Rarely — buyers assess utilisation and remaining useful life, and any outstanding device finance comes off the price at closing.
Can an online calculator value a med spa? No — a calculator performs arithmetic on figures you supply and cannot assess whether those figures would survive a buyer’s review.
When should an owner first look at valuation? Two or more years before any intended sale, while there is still time to change the factors that move the number.
Key takeaways
- Med spas are valued on a multiple of adjusted earnings — never on revenue, and never on the number of treatment rooms or devices.
- The earnings basis matters as much as the multiple: a 3x SDE multiple and a 5x EBITDA multiple can describe an identical price for an identical practice.
- The largest single discount in medical aesthetics is owner dependency — the degree to which patients book because of one injector rather than because of the practice.
- Recurring membership revenue is the most consistently rewarded value driver in the sector, because contracted revenue is easier for a buyer to underwrite than per-visit demand.
- No article, calculator, or advisor can tell an owner what a specific practice is worth without examining its financial records, provider mix, and patient data.
How are med spas valued?
Med spas are valued by applying a multiple to adjusted earnings — the practice’s profit, restated to show what a new owner would actually earn. Buyers arrive at that multiple by assessing how transferable the earnings are, how much of the revenue recurs, and how cleanly the practice would operate without the person selling it.
That is the whole method in two sentences. The rest of this article is about the two variables inside it — what goes into the earnings figure, and what moves the multiple — because that is where the money is.
Adjusted EBITDA, in plain English
EBITDA stands for earnings before interest, tax, depreciation and amortisation. It is an attempt to describe what a business earns from operating, stripped of decisions that belong to the owner rather than to the business: how it was financed, how it is taxed, and how it accounts for equipment ageing.
Adjusted EBITDA — sometimes called normalised or pro-forma EBITDA — goes one step further. It removes costs that exist because this particular owner runs the practice, and which would not exist for a new owner. In an owner-operated med spa, that usually means:
- Owner compensation above or below market. If an owner-injector pays themselves $400,000 and an employed replacement would cost $220,000, the buyer adds back the difference. If the owner has been paying themselves nothing and reinvesting, the buyer subtracts a market salary. This second direction surprises people, and it is not negotiable — the buyer has to employ someone to treat those patients.
- Personal expenses run through the practice. Vehicle, travel, phone, family members on payroll, conference attendance beyond what the business requires.
- One-time and non-recurring costs. A build-out, a legal dispute, a launch campaign for a second location, the cost of a discontinued service line.
- Rent above or below market, particularly where the owner holds the building through a separate entity.
The output is a single number that answers the buyer’s actual question: if I owned this practice next year, what would it earn me?
Why this matters more than the multiple. Owners tend to focus on the multiple, because it is the number that sounds like a verdict. But a change in the multiple moves the price proportionally, while a change in adjusted earnings moves it proportionally and compounds through the multiple. Sofer Advisors, reviewing 2026 med spa transactions, notes that proper identification of owner add-backs, one-time expenses and above-market owner compensation commonly moves adjusted EBITDA by $50,000 to $200,000 in a mid-sized practice.
Applied at a 5x multiple, $120,000 of accepted add-backs is $600,000 of enterprise value. A clean, well-documented add-back schedule can be worth more than a round of negotiation over the multiple, and it is entirely within the owner’s control in the two years before a sale.
SDE or adjusted EBITDA — which applies to your practice
This distinction causes more confusion than any other in medical aesthetics, and it is the reason two quoted multiples can be impossible to compare.
Seller discretionary earnings adds the owner’s entire compensation back to earnings. It describes what the business generates for one person who both owns and works in it. It is the right basis where the owner is the practice’s principal producer, and it is how business brokers price most single-location med spas.
Adjusted EBITDA does not add back owner compensation, because it assumes the owner’s clinical and management roles are filled by employed people at market rates. It is the right basis where the practice already runs on a provider bench and a manager.
The crossover typically sits somewhere between $500,000 and $1 million of earnings, though it is decided by the practice’s structure rather than strictly by its size.
The consequence: a practice quoted at 3x SDE and the same practice quoted at 5x adjusted EBITDA can produce almost the same price. When a buyer names a multiple, the first question is never is that good. It is a multiple of what.
Why revenue multiples are the wrong tool here
You will sometimes see practices discussed as a multiple of revenue — “one times collections,” or similar. Treat that with caution in medical aesthetics.
Two practices with identical revenue can have completely different earnings. One runs injectables at strong margin from two treatment rooms with modest overhead. The other runs the same top line across a larger footprint carrying three financed devices, a fuller staff roster, and heavier promotional spend. Identical revenue, very different profit, and a buyer is purchasing the profit.
Revenue multiples persist because they are easy to quote and because they flatter practices with high overhead. They are a conversation starter, not a valuation.
What “adjusted” does not cover
One caution on add-backs, because this is where sellers most often overreach. An add-back has to be genuinely non-recurring or genuinely owner-specific. Costs that are simply inconvenient do not qualify, and neither does revenue from an event that did not happen. Buyers routinely reject “lost revenue” adjustments, recurring costs relabelled as one-time, and anything without an invoice, a bank record, or a contract behind it.
A buyer’s quality of earnings review — more on this below — exists precisely to test each add-back. A schedule padded with optimistic entries damages credibility across the entire deal, including the entries that were legitimate.
What multiples do med spas actually sell for?
Med spa multiples rise sharply with size and with transferability. Published 2026 sources place owner-operated practices under $500,000 of seller discretionary earnings at roughly 2.1x to 3.9x SDE, single-location practices at 4x to 7x adjusted EBITDA, multi-location groups at 6x to 9x, and platform-scale businesses above 10x.
| Practice profile | Earnings basis | Typical range | Source and date |
|---|---|---|---|
| Single-provider, owner-operated, under $500K SDE | SDE | 2.1x – 3.9x | BizBuySell Q2 2025 Insight Report, cash-flow bands |
| Mature single or small multi-provider, $500K – $1.5M SDE | SDE | 3.5x – 6.0x | Skytale Group commentary; AmSpa 2025 look-back |
| Single location or add-on acquisition | Adjusted EBITDA | 4x – 7x | FOCUS Investment Banking Medspa Dashboard, January 2026 |
| Lower-middle-market group, $1M – $3M adjusted EBITDA | Adjusted EBITDA | 5.0x – 7.0x | FOCUS Investment Banking, 2026 |
| Multi-location platform | Adjusted EBITDA | 6x – 9x | Sorso valuation review, April 2026 |
| Regional chain, revenue above $20M | Adjusted EBITDA | 7x – 12x | Scope Research, March 2026 |
| National platform with scale and brand equity | Adjusted EBITDA | 10x+ | FOCUS Investment Banking, January 2026 |
For scale at the very top of the market: Reuters reported in June 2026 that LaserAway was running a sale process targeting a valuation above $2 billion against roughly $150 million of annual EBITDA — an implied multiple in the 13x to 14x band.
How to read that table
Three cautions before locating yourself in it.
The bands describe different businesses, not different sizes of the same business. A $12 million platform is not a large version of a $1.2 million practice. It has a management layer, a provider bench, systems that survive turnover, and a brand patients follow rather than an individual. That is what the higher multiple pays for.
The headline numbers circulating on social media are the top band. The 10x and 12x figures are real, and they belong to businesses very few readers own. Calibrating against them leads to disappointment at precisely the wrong moment.
Ranges are not offers. They describe the middle of a distribution. Individual transactions land outside them in both directions, for reasons that never make it into a published table.
What makes membership revenue different?
Membership revenue is contracted, recurring, and typically paid in advance of treatment, which makes it more predictable than per-visit demand. Buyers underwrite predictable revenue more favourably. This is the structural reason two med spas with identical earnings can receive offers a full turn apart.
Contracted, recurring, and predictable
A per-visit practice asks a buyer to believe that next year’s patients will book. Revenue depends on promotional cadence, competitive pressure, and how well the brand holds attention.
A practice with a membership base gives the buyer a contracted floor. Revenue for the coming year is substantially knowable at the start of it, given a retention assumption.
For a buyer — and particularly for a sponsor-backed platform financing the acquisition partly with debt — that predictability is the point. Contracted revenue supports leverage in a way that episodic demand does not.
FOCUS Investment Banking’s 2026 medspa dashboard reports that practices drawing 30 to 40 percent of revenue from memberships can add 0.5x to 1.0x turns of EBITDA against an otherwise comparable practice.
The related shift worth noticing
Guidepoint Qsight analysis from January 2025 found that practices actively running GLP-1 weight-management programmes recorded 9 percent revenue growth, while practices without them saw a 2 percent decline.
Part of that gap is demand. Part of it is structural, and the structural part is the more interesting one: GLP-1 programmes are monthly subscriptions inside what is otherwise a per-visit business. They convert episodic revenue into contracted revenue, which is precisely the shape buyers pay more for.
The limits of that premium
The premium is real, and it is conditional. It applies to the extent the recurring revenue is genuinely durable, which means:
- Retention is demonstrable, not asserted. A buyer needs to see renewal history at member level, not a confident estimate.
- The agreements transfer. A membership agreement that terminates on change of control, or is silent on assignment, is not the asset it appears to be.
- The relationship is with the practice. If members renew because of one injector who intends to slow down, the revenue is contracted but not durable.
The third point does most of the work in real transactions, and it is the subject of the next section.
What raises a med spa’s valuation?
Five factors consistently push a med spa valuation upward: earnings that survive the owner’s departure, recurring membership revenue, tenured providers under agreement, a balanced service mix, and financial records that withstand independent review. Each reduces a buyer’s perceived risk, and reduced risk is what a higher multiple actually represents.
Transferability, above everything else
Nothing else comes close. A buyer is underwriting cash flow that must exist without you. Every patient who books because of you personally is a patient the buyer discounts.
The signals buyers read: what share of injectable revenue you personally deliver, whether patients see more than one provider comfortably, whether the marketing sells the practice or sells you, and what happened to bookings the last time you took extended leave.
Provider retention and tenure
A practice where patients are seen by, and comfortable with, more than one injector is worth more than an otherwise identical practice built entirely around the founder.
Buyers look at tenure, at whether key providers are under agreement, and at whether those agreements survive a change of ownership. A tenured bench under contract is one of the few things that both raises the multiple and shortens diligence.
This is the highest-leverage structural change available to an owner planning an exit, and it takes years rather than months — which is why it belongs in a valuation article rather than a sale-preparation checklist.
Service mix and its concentration
Buyers assess balance across injectables, devices, body contouring, skincare, and any weight-management line — and they assess how concentrated the mix is.
Heavy concentration in a single service is a risk, whether that service is a device modality facing new competition or an injectable facing pricing pressure. Balanced practices are read as more durable. Practices that have diversified deliberately, with each line separately documented and independently profitable, are read as better managed.
Patient retention and the active file
Repeat rate and the size of the genuinely active patient file matter more than lifetime patient count. A large historical database with a small active core describes promotional revenue rather than durable demand, and buyers can tell the difference from the booking data.
Build this record before you need it. Retrospective reconstruction during diligence is possible, slow, and rarely flattering.
Financial records that survive review
Assume every figure will be independently verified. Practices whose books need reconstruction rather than verification lose value twice — once in the corrected numbers, and again in the credibility cost that follows.
What quietly lowers a med spa’s valuation?
Most valuation surprises are downward, and most of them are foreseeable. The five below account for a substantial share of the gap between what an owner expects and what a buyer offers. None of them appears prominently on broker websites, because none of them helps sell an engagement.
Owner dependency — the largest single discount
This is the one. If patients came for you, book with you, and would follow you out of the door, then what is for sale is substantially your relationships rather than a business — and relationships do not transfer at closing.
This is the hardest conversation in a sell-side process, because the thing being discounted is usually the owner’s proudest achievement. You built the book. Patients ask for you by name. That is precisely the problem.
The consequences show up in two ways: a lower multiple, and more of the price deferred into an earnout or rollover equity that pays only if the earnings survive. Owners frequently focus on the headline number and discover the structure later. The structure is where owner dependency is actually priced.
Undocumented patient and membership churn
An owner reports strong retention. Diligence examines the roster over several years and finds cancellations that were never systematically recorded, members carried on the list after they stopped paying, and a real churn rate meaningfully different from the reported one.
The valuation impact of the corrected number is one problem. The credibility impact is a larger one: every other figure the seller has provided is now re-examined. This is a leading cause of price reductions between the letter of intent and closing, and it is entirely preventable with disciplined record-keeping.
Device economics — why lasers rarely add what owners expect
Owners frequently expect device investment to lift valuation. It usually does not, and sometimes it does the opposite.
Buyers assess three things:
Utilisation. An underused platform is a fixed cost, not an asset. Buyers look at treatments per device per month, not at the equipment list.
Remaining useful life. A device three years into a five-year cycle is a capital expenditure the buyer inherits, and that spending comes off the price.
Financing. Device debt is real debt. It is settled at closing from the proceeds, which means it reduces what reaches you regardless of what the device contributes clinically.
A well-utilised device that carries its own operating cost supports earnings, and earnings are what get multiplied. The device itself is rarely valued separately.
Prepaid packages and unredeemed treatments
This one is specific to medical aesthetics and it catches sellers out repeatedly.
Package revenue collected in advance represents an obligation to deliver treatment later. Buyers treat the unredeemed portion as a liability that must be funded at closing, and they will look for it whether or not the balance sheet shows it clearly.
Practices that recognise package revenue on collection rather than on delivery frequently discover during diligence that both their earnings and their working capital position look different under a buyer’s accounting than under their own. Neither correction is welcome at that stage.
The same logic applies to unredeemed memberships and gift certificates, and it feeds directly into the working capital peg — the amount of working capital you are required to leave in the business at closing.
Compliance and structural exposure
Corporate structure, medical director arrangements, supervision documentation, and injector scope of practice are examined in legal diligence, and defects there change deal terms rather than just deal price — larger escrow, specific indemnity carve-outs, a holdback pending remediation, occasionally a withdrawn buyer.
This is not a valuation input in the arithmetic sense. It is a valuation input in the practical sense, because a buyer who inherits risk prices it.
What does a valuation range actually mean — and what it doesn’t?
A valuation range is an estimate of what a category of buyers might pay under a set of assumptions. It is not a price, not an offer, and not a promise. Two practices with identical financials can transact at materially different prices depending on buyer type, deal structure, timing, and how the process is run.
Why no article can tell you your number
Everything in this article describes how the calculation works. None of it can produce your figure, because the figure depends on your financial records, your provider mix, your membership data, your device obligations, and your lease — none of which are visible from here.
Be sceptical of any source that produces a number for you without seeing those things. That includes online calculators, which perform arithmetic on inputs you supply and cannot assess whether the inputs would survive review. They are useful for understanding the mechanics. They are not a valuation, and where they exist primarily to capture your contact details, that is worth knowing.
Enterprise value and what actually reaches you
The headline number in a transaction is enterprise value. What an owner receives is a different figure, after:
- Debt repayment, including practice loans and device finance
- Working capital adjustments — the buyer expects a normal level of working capital to remain in the business, and in medical aesthetics that calculation is complicated by prepaid packages and unredeemed memberships
- Escrow or holdback, a portion retained against post-closing claims
- Deferred consideration — earnout or rollover equity, paid later and conditionally
- Transaction costs — advisory, legal, and accounting fees
- Tax, which depends on deal structure and on your circumstances
The gap between enterprise value and net proceeds is routinely larger than sellers anticipate. Ask your advisor to model it early, and ask your own tax counsel to review the structure. Nothing in this article is tax advice.
A worked example
Illustrative only. Not a market claim, and not a valuation of any real practice.
A two-location practice reports $780,000 of EBITDA on $3.1 million of revenue.
| Line | Amount |
|---|---|
| Reported EBITDA | $780,000 |
| Add back: owner compensation above market | +$95,000 |
| Add back: personal vehicle and travel | +$28,000 |
| Add back: one-time legal fees | +$22,000 |
| Deduct: market-rate manager not currently employed | –$85,000 |
| Adjusted EBITDA | $840,000 |
At a range of 4.5x to 6.0x, that is roughly $3.8 million to $5.0 million of enterprise value — a $1.2 million spread on one practice.
What decides where inside it an offer lands: the owner still personally delivers a large share of injectable revenue, which pulls toward the bottom. Memberships are 22 percent of revenue, approaching but not at the threshold where the premium begins. Two of three injectors have been in place over three years, which helps. There is $180,000 of device debt, which comes off the top.
Same practice, same earnings, and the answer is still a range — because that is what the evidence supports.
How do buyers test your numbers? Quality of earnings
A quality of earnings review — usually shortened to QoE — is an independent accounting analysis a buyer commissions to verify that reported earnings are accurate and sustainable. It is not an audit. It is a targeted examination of whether the earnings a seller has presented are real, recurring, and correctly stated. It is standard above roughly $1 million of adjusted EBITDA.
In a med spa transaction, a QoE typically examines:
- Each add-back in the adjusted earnings schedule, individually
- Revenue by service line and by provider, tested against bank deposits
- Membership retention and churn, calculated independently from the roster
- Related-party arrangements, particularly rent and family payroll
- Revenue recognition on packages and memberships sold in advance
- Deferred revenue — treatments paid for but not yet delivered
- Product and consumable inventory, and purchasing records against authorised distributor channels
The deferred revenue item catches sellers out most often. Package revenue collected in January represents an obligation to deliver treatment across the rest of the year, and buyers treat the unearned portion as a liability to be funded at closing.
The practical implication is straightforward: assume every figure you present will be independently verified. Present numbers you can support, disclose the ones that need explanation before they are discovered, and the process moves faster and at a better price.
Frequently asked questions
How is a med spa valued?
A med spa is valued by applying a multiple to adjusted earnings — either seller discretionary earnings or adjusted EBITDA, depending on whether the owner is the practice’s principal producer. The multiple reflects transferability, recurring revenue, provider retention, service mix, and the quality of the financial records.
What multiple do med spas sell for?
Published 2026 sources place single-location practices at roughly 4x to 7x adjusted EBITDA and multi-location groups at 6x to 9x, with owner-operated practices under $500,000 of seller discretionary earnings at 2.1x to 3.9x SDE. Ranges are context, not a prediction for any specific practice.
What is the difference between EBITDA and adjusted EBITDA?
EBITDA is earnings before interest, tax, depreciation and amortisation. Adjusted EBITDA additionally removes owner-specific and non-recurring costs — above-market owner compensation, personal expenses, one-time items — to show what the practice would earn under new ownership.
Does membership revenue increase what my med spa is worth?
Yes, where the recurring revenue is a meaningful share of the top line and the retention can be demonstrated. FOCUS Investment Banking’s 2026 dashboard reports that practices drawing 30 to 40 percent of revenue from memberships can add 0.5x to 1.0x turns of EBITDA against an otherwise comparable practice.
Will buying more devices increase my valuation?
Rarely, in itself. Buyers assess utilisation and remaining useful life rather than the equipment list, and outstanding device finance is settled at closing from the proceeds. A well-used device supports earnings, and earnings are what get multiplied.
Does my practice have value if I am the only injector?
Yes, though owner dependency typically reduces the multiple and shifts more of the consideration into deferred forms such as earnouts or rollover equity. Single-provider practices transact regularly; the structure simply reflects the transition risk.
Can I get a valuation without putting my practice on the market?
Yes. A confidential valuation assessment can be prepared without approaching buyers, without a listing, and without your staff or patients being aware. Many owners do this years before any decision to sell.
